C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s

Keith Henry, Douglas Kitch, Michael Dube, Robert Zackin, Robert A. Parker, Dennis Sprecher, Scott Hammer, Judith Currier

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an average of 42 months of indinavir-based highly active antiretroviral therapy (HAART). Pre-HAART CRP levels were determined for 79 patients, and an additional CRP value was obtained after an average of 31 additional months of HAART in 56. CRP levels were elevated but tended to be stable or decrease with indinavir-based HAART over extended periods of exposure.

Original languageEnglish (US)
Pages (from-to)2434-2437
Number of pages4
JournalAIDS
Volume18
Issue number18
StatePublished - Dec 3 2004

Fingerprint Dive into the research topics of 'C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s'. Together they form a unique fingerprint.

Cite this